Voloridge Investment Management »

Enliven Therapeutics shares owned by Voloridge Investment Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Voloridge Investment Management from 13F filings

Historical chart of Voloridge Investment Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Voloridge Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $442k 17k 25.54
2024-06-30 $272k 12k 23.37

More positions owned by Voloridge Investment Management

Ishares Tr Core S&p500 Etf (IVV)
AmerisourceBergen (COR)
Mastercard Incorporated Cl A (MA)
MercadoLibre (MELI)
Merck & Co (MRK)
Marsh & McLennan Companies (MMC)
Apple (AAPL)
Cme (CME)
AutoZone (AZO)
Cava Group Ord (CAVA)
Illinois Tool Works (ITW)
McKesson Corporation (MCK)
Lockheed Martin Corporation (LMT)
Waste Management (WM)
TJX Companies (TJX)

View all positions for Voloridge Investment Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics